Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AURORA 2: Long-term double-blind continuation of voclosporin vs placebo in lupus nephritis
jRCT2080224051Phase 3Completed
- Sponsor
- Aurinia
- Start
- Sep 2018
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in lupus nephritis (LN) comparing Voclosporin continuation arm with Placebo continuation arm (2 arms). Primary endpoint: Long-term safety profile of voclosporin. Started Sep 2018; status: completed.
02
Drugs
voclosporin
03
Conditions
lupus nephritis (LN)
Beyond the preview
Go deeper on jRCT2080224051.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224051.